Deutsche Bank reiterates its Buy rating on United Therapeutics (Nasdaq: UTHR), calling the Company its top mid-cap pick for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE